Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The repair Schwann cell and its function in regenerating nerves.
'The worm that got away': parainfectious atypical optic neuritis associated with schistosomiasis infection.
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain.
Multiple Sclerosis-related Uveitis: Does MS Treatment Affect Uveitis Course?
Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood.
Albumin heterogeneity in low-abundance fluids. The case of urine and cerebro-spinal fluid.
Boswellic acids reduce TH17 differentiation via blockade of IL-1β-Mediated IRAK1 signaling.
[Multiple sclerosis and pelviperineology: Urinary and sexual dysfunctions and pregnancy].
Tract-based spatial statistics of the olfactory brain in patients with multiple sclerosis.
The choroid plexus is modulated by various peripheral stimuli: implications to diseases of the central nervous system.
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.
Impaired functional integration in multiple sclerosis: a graph theory study.
A pilot randomized trial of progressive resistance exercise augmented by neuromuscular electrical stimulation for people with Multiple Sclerosis who use walking aids.
SPECIFIC TARGETING OF THE IL-23 RECEPTOR USING A NOVEL SMALL PEPTIDE NON-COMPETITIVE ANTAGONIST, DECREASES THE INFLAMMATORY RESPONSE.
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.
Spinal anesthesia for cesarean delivery in a woman with neuromyelitis optica.
Sex-Based Differences in Multiple Sclerosis (Part I): Biology of Disease Incidence.
[Oral treatments in multiple sclerosis].
Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis-A Cohort Study.
Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Cerebrospinal fluid analysis in the context of CNS demyelinating diseases.
[Molecular targeted therapy for neuroimmunological diseases].
Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis - insights into possible drug mechanism.
Pages
« first
‹ previous
…
588
589
590
591
592
593
594
595
596
…
next ›
last »